Cargando…
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The aim of the present review is to report the available evidence on the interaction between these two infections. Differences and similarities of TB and COVID-19, their immunological features, diagnostics, epidemiol...
Autores principales: | Visca, D., Ong, C.W.M., Tiberi, S., Centis, R., D’Ambrosio, L., Chen, B., Mueller, J., Mueller, P., Duarte, R., Dalcolmo, M., Sotgiu, G., Migliori, G.B., Goletti, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825946/ https://www.ncbi.nlm.nih.gov/pubmed/33547029 http://dx.doi.org/10.1016/j.pulmoe.2020.12.012 |
Ejemplares similares
-
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021) -
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016) -
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017) -
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts
por: Motta, I., et al.
Publicado: (2020) -
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)